NO175040C - - Google Patents

Info

Publication number
NO175040C
NO175040C NO870560A NO870560A NO175040C NO 175040 C NO175040 C NO 175040C NO 870560 A NO870560 A NO 870560A NO 870560 A NO870560 A NO 870560A NO 175040 C NO175040 C NO 175040C
Authority
NO
Norway
Prior art keywords
pregnanolone
claving
pregnan
alfa
sterilized
Prior art date
Application number
NO870560A
Other languages
English (en)
Norwegian (no)
Other versions
NO175040B (no
NO870560L (no
NO870560D0 (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO870560D0 publication Critical patent/NO870560D0/no
Publication of NO870560L publication Critical patent/NO870560L/no
Publication of NO175040B publication Critical patent/NO175040B/no
Publication of NO175040C publication Critical patent/NO175040C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
NO870560A 1986-02-13 1987-02-12 Fremgangsmåte for fremstilling av et preparat for intravenös administrering av 3 NO175040B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition

Publications (4)

Publication Number Publication Date
NO870560D0 NO870560D0 (no) 1987-02-12
NO870560L NO870560L (no) 1987-08-14
NO175040B NO175040B (no) 1994-05-16
NO175040C true NO175040C (cs) 1994-08-24

Family

ID=20363448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870560A NO175040B (no) 1986-02-13 1987-02-12 Fremgangsmåte for fremstilling av et preparat for intravenös administrering av 3

Country Status (14)

Country Link
US (1) US5028600A (cs)
EP (1) EP0233849B1 (cs)
JP (1) JPH0788305B2 (cs)
AT (1) ATE64526T1 (cs)
CA (1) CA1301651C (cs)
DE (1) DE3770830D1 (cs)
DK (1) DK175504B1 (cs)
ES (1) ES2037742T3 (cs)
FI (1) FI88676C (cs)
GR (1) GR3002299T3 (cs)
HK (1) HK83293A (cs)
NO (1) NO175040B (cs)
SE (1) SE8600632D0 (cs)
SG (1) SG102892G (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US6117429A (en) * 1997-08-11 2000-09-12 Weider Nutrition International, Inc Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors
CN1221249C (zh) 1998-08-19 2005-10-05 斯凯伊药品加拿大公司 普鲁泊福的可注射水分散体
WO2002053102A2 (en) * 2000-12-29 2002-07-11 The Trustees Of Columbia University In The City Of New York Use of iv emulsions with different triglyceride composition, particle size and apolipoprotein e for targeted tissue delivery of hydrophobic compounds
CA2491724C (en) * 2002-07-02 2013-04-02 Altana Pharma Ag Ciclesonide-containing sterile aqueous suspension
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20080262084A1 (en) * 2004-09-13 2008-10-23 Gautam Vinod Daftary Stable Emulsion Compositions for Intravenous Administration Having Preservatie Efficacy
CN103491976B (zh) * 2011-01-14 2015-04-01 卡思伯特·O·辛普金斯 用于处理与缺乏血液供给、休克和神经损伤相关的疾病的方法和组合物
US10478505B2 (en) 2011-09-23 2019-11-19 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
SMT202000008T1 (it) 2012-01-23 2020-03-13 Sage Therapeutics Inc Formulazione di steroide neuroattivo comprendente un complesso di allopregnanolone e solfobutil eter beta-ciclodestrina
WO2014028398A2 (en) 2012-08-13 2014-02-20 The Regents Of The University Of California Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
HRP20220005T1 (hr) 2012-08-21 2022-04-01 Sage Therapeutics, Inc. Alopregnanolon za liječenje refraktornog epileptičnog statusa
US20150313915A1 (en) 2012-11-30 2015-11-05 The Regents Of The University Of California Anticonvulsant activity of steroids
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
TW202400182A (zh) 2016-03-08 2024-01-01 美商賽吉醫療公司 神經活性類固醇，其組合物及用途
KR20210102936A (ko) * 2018-12-10 2021-08-20 헤일로 사이언스 엘엘씨 안정적인 마취제 제제 및 관련 복용량 형태
EP4017498A4 (en) * 2019-08-19 2022-11-09 Arizona Board of Regents on behalf of the University of Arizona TOPICAL NEUROSTEROID FORMULATIONS
US11969434B1 (en) 2022-08-29 2024-04-30 Lipocine Inc. Oral allopregnanolone compositions and methods of use
CN114344309B (zh) * 2021-12-30 2024-02-06 南京迈诺威医药科技有限公司 一种别孕烷醇酮衍生物自乳化制剂及其制备方法
US12186327B2 (en) 2022-08-29 2025-01-07 Lipocine Inc. Oral allopregnanolone compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1215702B (de) * 1962-07-03 1966-05-05 Merck Ag E Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen
CA895860A (en) * 1969-11-05 1972-03-21 Kruger Gunther PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液

Also Published As

Publication number Publication date
FI870589L (fi) 1987-08-14
NO175040B (no) 1994-05-16
EP0233849B1 (en) 1991-06-19
US5028600A (en) 1991-07-02
DK175504B1 (da) 2004-11-15
FI88676C (fi) 1993-06-28
ES2037742T3 (es) 1993-07-01
FI870589A0 (fi) 1987-02-12
NO870560L (no) 1987-08-14
FI88676B (fi) 1993-03-15
JPH0788305B2 (ja) 1995-09-27
GR3002299T3 (en) 1992-12-30
DK62187D0 (da) 1987-02-06
SE8600632D0 (sv) 1986-02-13
CA1301651C (en) 1992-05-26
HK83293A (en) 1993-08-20
SG102892G (en) 1992-12-04
DE3770830D1 (de) 1991-07-25
NO870560D0 (no) 1987-02-12
JPS62192322A (ja) 1987-08-22
ATE64526T1 (de) 1991-07-15
DK62187A (da) 1987-08-14
EP0233849A1 (en) 1987-08-26

Similar Documents

Publication Publication Date Title
GR3002299T3 (en) Composition of pregnanolole comprising a stable oil-in-water emulsion
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
ES8504678A1 (es) Procedimiento para la preparacion de un derivado de insulina
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
MY101784A (en) Novel pharmacological compounds
IL75637A0 (en) Thymopentin analogs and pharmaceutical compositions containing them
WO1987006226A3 (en) Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
ZA85441B (en) 6,6-ethylene-15,16-methylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactones,processes for the production thereof,and pharmaceutical preparations containing them
FR2688499B1 (fr) Procede de preparation de la beta-phenylisoserine et de ses analogues.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
DE69018730D1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES471507A1 (es) Procedimiento para la obtencion de piperidino-propanoles
ES8704487A1 (es) Procedimiento para preparar derivados de 3,4-diazol
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
ES8303324A1 (es) "procedimiento para preparar una sustancia activa adecuada para la estabilizacion de prostaglandinas y sus derivados".
EP0260606A3 (en) Medicament for curing neurotic disturbance or disorder comprising sialocylglycerolipid
UA16000A1 (uk) Спосіб лікуваhhя гіпотрофії поросят
KR890001582A (ko) 향류머티스제
JO1531B1 (en) New near-compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees